Sircle Laboratories

Sircle Laboratories was a privately held pharmaceutical company based in Olive Branch, Mississippi, that specialized in the development and commercialization of generic injectable drug products. The company focused on building a portfolio of Abbreviated New Drug Applications (ANDAs) to provide cost-effective alternatives for essential medications in the hospital and clinical settings. In April 2015, Sircle Laboratories was acquired by Sagent Pharmaceuticals for $20 million in cash plus potential milestone payments. The acquisition was designed to expand Sagent's product offerings and strengthen its development pipeline within the generic injectables market.